EVOBRIG

View On IPO.GOV.UK

Registered

on 3 Aug 2017

Last Applicant/ Owned by

Takeda Pharmaceuticals U.S.A., Inc.

500 Kendall Street, Cambridge, Massachusetts

, , 02142

Serial Number

UK00917063471 filed on 3^rd Aug 2017

Registration Number

UK00917063471 registered on
20^th Nov 2017

Correspondent Information

Potter Clarkson LLP

Chapel Quarter, Mount Street

Nottingham,

NG1 6HQ

EVOBRIG

pharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inf Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer.

Mark Details

Serial Number

UK00917063471

Mark Type

Word

Kind of mark

Individual

EVOBRIG

Classification Information

Class [5]Pharmaceutical Products

Mark Details

Serial Number

Mark Type

Kind of mark

Class [5]
Pharmaceutical Products